The diagnosis and correction of hemocoagulation disorders in operative delivery

Tarabrin, O.; Mazurenko, A.; Tarabrin, P.; Sazhyn, D.; Volodychev, D.

dc.contributor.author	Tarabrin, O.	en
dc.contributor.author	Mazurenko, A.	en
dc.contributor.author	Tarabrin, P.	en
dc.contributor.author	Sazhyn, D.	en
dc.contributor.author	Volodychev, D.	en
dc.date.accessioned	2020-06-13T06:33:57Z
dc.date.available	2020-06-13T06:33:57Z
dc.date.issued	2017
dc.identifier.citation	The diagnosis and correction of hemocoagulation disorders in operative delivery / O. Tarabrin, A. Mazurenko, P. Tarabrin et al. // European Journal of Anaesthesiology. 2017. Vol. 34, Suppl. 55. N 12AP04-5. (Euroanaesthesia 2017: The European Anaesthesiology Congress, Geneva, Switzerland, 3-5 june 2017 : Abstracts)	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7327
dc.description.abstract	Despite significant progress in obstetric care, the problem of bleeding during labour remains unfinished. Annually in the world 125,000 women die from obstetric haemorrhage. The results of surgical treatment of 84 patients after cesarean section during the period from 2014 to 2016 entered the study. Condition of haemostasis was monitored by 12 standard biochemical tests, as well as the new instrumental method – low-frequency piezoelectric haemoviscoelastography preoperative, intra-operative and every day during 10 days af ter surgery.A randomized, double-blind study was performed .Patients were divided into two groups: the first group (n=43) received preoperative (30 minutes before operation) tranexamic acid 10-15 mg/kg (depends on severity of hemocougulation disorders); the second group (n=41) didn’t receive medication, which has influence on blood coagulation.	en
dc.language.iso	en	en
dc.subject	operative delivery	en
dc.subject	hemocoagulation disorders	en
dc.title	The diagnosis and correction of hemocoagulation disorders in operative delivery	en
dc.type	Article	en